What clinical trials are available for locally advanced Ovarian Cancer

Clinical Trials for Locally Advanced Ovarian Cancer

I appreciate your question about clinical trial options. Let me provide you with educational information about how clinical trials work for ovarian cancer, and then help you understand what questions to ask your care team.

Understanding Your Situation

"Locally advanced" ovarian cancer typically means the cancer has spread beyond the ovary but remains in the pelvis and/or abdomen without distant metastases (spread to distant organs). According to NCCN Guidelines for Ovarian Cancer, treatment decisions for advanced ovarian cancer depend on several factors including:

• Stage (how far the cancer has spread)
• Histology (what type of ovarian cancer cells you have)
• Molecular testing results (BRCA status, HRD status, MSI/MMR status, and other biomarkers)
• Performance status (your overall health and ability to tolerate treatment)

General Treatment Approaches in Clinical Trials

For advanced ovarian cancer, clinical trials typically investigate:

1. Chemotherapy-Based Combinations

• Standard approaches combine platinum drugs (carboplatin or cisplatin) with paclitaxel
• Trials may test different delivery methods (intravenous vs. intraperitoneal)
• Some trials combine chemotherapy with newer targeted agents

2. Targeted Therapy Trials

• PARP inhibitors (olaparib, niraparib, rucaparib) - especially for BRCA-mutated cancers
• Bevacizumab (anti-angiogenic therapy that cuts off blood supply to tumors)
• Folate receptor alpha (FRα) targeted therapies like mirvetuximab soravtansine
• Immunotherapy combinations with checkpoint inhibitors

3. Combination Approaches According to NCCN Guidelines, newer trials often combine:

• Chemotherapy + bevacizumab
• Chemotherapy + PARP inhibitors
• Bevacizumab + PARP inhibitors
• Immunotherapy + chemotherapy + bevacizumab

Why Molecular Testing Matters for Trial Eligibility

Before you can enroll in most advanced ovarian cancer trials, your tumor should be tested for:

• BRCA1/2 mutations (germline and somatic)
• HRD (Homologous Recombination Deficiency) status
• MSI/MMR status (for immunotherapy eligibility)
• FRα expression (for targeted therapy trials)
• BRAF, RET, NTRK mutations (for specific targeted trials)

According to NCCN Guidelines, "validated molecular testing should be performed in a CLIA-approved facility using the most recent available tumor tissue."

How to Find Clinical Trials

Official Resources:

• ClinicalTrials.gov - Search by cancer type, location, and trial phase
• NCI Cancer Clinical Trials (cancer.gov) - National Cancer Institute's trial database
• Your cancer center's research department - Often has trials specific to your institution
• NCCN Member Institutions - Comprehensive cancer centers typically have active trial programs
• Advocacy organizations - Organizations like the Ovarian Cancer Research Alliance may have trial information

Important Questions to Ask Your Oncology Team

Since I cannot tell you which specific trials are currently enrolling in your area, here are the critical questions to ask your care team:

1. "Based on my tumor's molecular testing results (BRCA status, HRD status, etc.), which clinical trials am I eligible for?"

2. "Are there trials available at our institution or nearby that match my stage and tumor characteristics?"

3. "What is the primary goal of the trial - is it testing a new drug, a new combination, or a new delivery method?"

4. "What are the potential benefits and risks compared to standard treatment for my stage?"

5. "Will I be randomized (randomly assigned) to different treatment groups, or will I receive the investigational treatment?"

6. "What are the time commitments and monitoring requirements if I enroll?"

7. "Are there any trials specifically designed for my tumor type?" (This is especially important if you have clear cell, mucinous, or other less common ovarian cancer types)

8. "If the trial stops working for me, what are my next treatment options?"

Special Considerations

According to NCCN Guidelines, for locally advanced ovarian cancer, your treatment may involve:

• Primary debulking surgery (removing as much cancer as possible) followed by chemotherapy, OR
• Neoadjuvant chemotherapy (chemotherapy first) followed by interval debulking surgery

Some clinical trials specifically test whether one approach is better than the other, or test new drugs within these frameworks.

Next Steps

1. Ensure complete molecular testing - If not already done, ask your team to order comprehensive tumor molecular testing
2. Request a trial search - Ask your oncologist or research coordinator to search for trials matching your specific situation
3. Get written information - Request detailed information about any trials you're considering
4. Take time to decide - You don't need to rush into a trial; discuss pros and cons thoroughly with your team

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncology team has access to real-time trial databases and knows your complete medical picture, making them the best resource for identifying trials that are right for YOUR specific situation.